These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16127777)

  • 1. Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer.
    Jeong J; Park YN; Park JS; Yoon DS; Chi HS; Kim BR
    Yonsei Med J; 2005 Aug; 46(4):519-25. PubMed ID: 16127777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant p16INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer.
    Naka T; Kobayashi M; Ashida K; Toyota N; Kaneko T; Kaibara N
    Int J Oncol; 1998 May; 12(5):1111-6. PubMed ID: 9538137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
    Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
    Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
    J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
    J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
    Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Okai T; Sawabu N
    Clin Cancer Res; 1997 Sep; 3(9):1473-7. PubMed ID: 9815833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
    Tokman B; Gultekin SE; Sezer C; Alpar R
    Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
    Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
    Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
    Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
    World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.
    Ohtsubo K; Watanabe H; Yamaguchi Y; Hu YX; Motoo Y; Okai T; Sawabu N
    J Gastroenterol; 2003; 38(7):663-71. PubMed ID: 12898359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of expression of p53, p16, and cyclooxygenase 2 in pancreatic cancer by tissue microarray and correlation among these three genes].
    Li YM; Yu ZH; Li L; Xu P; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):939-42. PubMed ID: 16759529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
    Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
    Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of PTEN, p16, p21, and p53 proteins in lung cancer using tissue microarray and their clinical significance].
    Liao XB; Hu DX; Zhou XM; Yu FL; Yuan YC; Chen MJ
    Ai Zheng; 2004 Mar; 23(3):334-8. PubMed ID: 15025970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas.
    Engelsen IB; Stefansson I; Akslen LA; Salvesen HB
    Am J Obstet Gynecol; 2006 Oct; 195(4):979-86. PubMed ID: 16677592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.